CTLA4 and graft versus host disease: In this study, we have explored the kinetics of expression of three inhibitory immune checkpoint pathways, PD-1/PD-L1, CTLA-4, and foxp3+ Tregs, that are relevant to the control of GvHD in allo-HSCT recipients.